Together, our study revealed that SUMOylation inhibition enhances Len sensitivity in MM by decreasing IRF4 transcription level via downregulating DOT1L and IRF4 protein level via promoting degradation. The gene discussed is DOT1L; the disease is Miyoshi myopathy.